Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 17/20 | 0.58 |
| ▸ | ADORA1 | P30542 | 9/20 | 0.57 |
| ▸ | ADORA2A | P29274 | 6/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13534708 | 0.90 | ADORA2B (0.49) | ADORA2BADORA1ADORA2AMAPK1ALDH1A1 | |
| SCHEMBL1780170 | 0.73 | ADORA2B (1.00) | ADORA2BADORA1ADORA2A | |
| SCHEMBL1222451 | 0.73 | ADORA2B (1.00) | ADORA2BADORA1ADORA2A | |
| SCHEMBL14517874 | 0.67 | ADORA2B (0.82) | ADORA2BADORA1ADORA2A | |
| SCHEMBL14517867 | 0.65 | ADORA2B (0.79) | ADORA2BADORA1ADORA2AALDH1A1ADORA3 | |
| SCHEMBL1779353 | 0.65 | ADORA2B (0.80) | ADORA2BADORA1ADORA2A | |
| SCHEMBL7731102 | 0.65 | ADORA2B (0.50) | ADORA2BADORA1ADORA2A | |
| SCHEMBL7731097 | 0.65 | ADORA2B (0.50) | ADORA2BADORA1ADORA2A | |
| SCHEMBL14267734 | 0.63 | ADORA2B (1.00) | ADORA2BADORA1ADORA2A | |
| SCHEMBL14293825 | 0.61 | ADORA2B (0.81) | ADORA2BADORA1ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011123518-A1 | ADENOSINE RECEPTOR AGONISTS FOR THE TREATMENT AND PREVENTION OF VASCULAR OR JOINT CAPSULE CALCIFICATION DISORDERS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2011-10-06 | — | — | WO | disclosed |